The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer

被引:0
|
作者
Hjorth, Cathrine
Damkier, Per
Stage, Tore B.
Feddersen, Soren
Hamilton-Dutoit, Stephen
Ejlertsen, Bent
Lash, Timothy L.
Boggild, Henrik
Sorensen, Henrik
Cronin-Fenton, Deirdre
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P5-03-11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-03-11
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Return-to-work after radiotherapy for prostate cancer
    Sveistrup, Joen
    Petersen, Peter Meidahl
    Mortensen, Ole Steen
    Engelholm, Svend Aage
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [32] Recurrent or metastatic endometrial cancer: Prognostic factors after taxane-based systemic chemotherapy
    Mountzios, G.
    Bamias, A.
    Papadimitriou, D.
    Pissalkas, E.
    Bozas, G.
    Lainakis, G.
    Lianos, E.
    Kastritis, E.
    Dimopoulos, M. A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 322 - 322
  • [33] Impact of breast cancer care pathways and related symptoms on the return-to-work process
    Bertin, M.
    Rolland, A. L.
    Porro, B.
    Roquelaure, Y.
    Kab, S.
    Ribet, C.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [34] Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer
    Nakabayashi, Mari
    Oh, William K.
    Jacobus, Susanna
    Regan, Meredith M.
    Taplin, Mary-Ellen
    Kantoff, Philip W.
    Rosenberg, Jonathan E.
    BJU INTERNATIONAL, 2010, 105 (10) : 1392 - 1396
  • [35] Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
    Small, Brent J.
    Lange, Marie
    Zhai, Wanting
    Ahn, Jaeil
    Ahles, Tim A.
    Carroll, Judith E.
    Cohen, Harvey J.
    Graham, Deena
    Extermann, Martine
    Heutte, Natacha
    Jim, Heather S. L.
    McDonald, Brenna C.
    Patel, Sunita K.
    Root, James C.
    Saykin, Andrew J.
    Van Dyk, Kathleen
    Zhou, Xingtao
    Mandelblatt, Jeanne
    Joly, Florence
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 459 - 469
  • [36] Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis
    Brent J. Small
    Marie Lange
    Wanting Zhai
    Jaeil Ahn
    Tim A. Ahles
    Judith E. Carroll
    Harvey J. Cohen
    Deena Graham
    Martine Extermann
    Natacha Heutte
    Heather S. L. Jim
    Brenna C. McDonald
    Sunita K. Patel
    James C. Root
    Andrew J. Saykin
    Kathleen Van Dyk
    Xingtao Zhou
    Jeanne Mandelblatt
    Florence Joly
    Breast Cancer Research and Treatment, 2022, 191 : 459 - 469
  • [37] Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review
    Fernandes, Ricardo
    Mazzarello, Sasha
    Hutton, Brian
    Shorr, Risa
    Majeed, Habeeb
    Ibrahim, Mohammed F. K.
    Jacobs, Carmel
    Ong, Michael
    Clemons, Mark
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3633 - 3650
  • [38] First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
    Bazan, F.
    Dobi, E.
    Villanueva, C.
    Nerich, V.
    Compagnat, F.
    Thiery-Vuillemin, A.
    Chaigneau, L.
    Nguyen, T.
    Limat, S.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S345 - S345
  • [39] Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer
    J. M. Andrade
    H. H. A. Carrara
    F. F. Pimentel
    H. R. C. Marana
    A. H. Macchetti
    L. R. Mouro
    F. E. Zola
    D. G. Tiezzi
    Medical Oncology, 2011, 28 : 65 - 69
  • [40] Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients
    Alacacioglu, Ahmet
    Zengel, Baha
    Denecli, Ali Galip
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (04): : 454 - 458